Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 14/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | SHBG | P04278 | 3/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.61 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.61 |
| ▸ | PGR | P06401 | 2/20 | 0.61 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.61 |
| ▸ | AR | P10275 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | SNCA | P37840 | 2/20 | 0.61 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.61 |
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.61 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12430769 | 1.00 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL11020843 | 1.00 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL4361013 | 1.00 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL13787743 | 1.00 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL13752636 | 1.00 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL4431797 | 1.00 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL13001778 | 1.00 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| Sulfuric Acid SCHEMBL15901696 | 0.95 | CYP19A1 (0.91) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| Diethylamine SCHEMBL8741602 | 0.92 | CYP19A1 (0.85) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| Propionic Acid SCHEMBL29224763 | 0.92 | CYP19A1 (0.85) | CYP19A1LMNAMAPTSHBGCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 18890 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137650-A1 | MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs) | 11949098 CANADA INC (CA) | 2026-05-21 | — | — | US | claimed |
| EP-4718074-A2 | MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA | Quest Diagnostics Investments Incorporated (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4709383-A1 | INVERSE AGONISTS OF RAR RELATED ORPHAN RECEPTORS (RORS) | 11949098 Canada Inc. (CA) | 2026-03-18 | — | — | EP | claimed |
| US-12577324-B2 | Antibodies having specificity to HER4 and uses thereof | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2026-03-17 | — | — | US | claimed |
| EP-3699174-B1 | COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME | ILAB (KR) | 2025-11-12 | — | — | EP | claimed |
| US-20250326856-A1 | HUMANIZED ANTI-CD45 ANTIBODIES AND USES THEREOF | Fred Hutchison Cancer Center (US) | 2025-10-23 | — | — | US | claimed |
| US-20250277045-A1 | DEVELOPMENT AND APPLICATION OF T-CELL ENGAGER THERAPEUTIC AGENT | KEYMED BIOSCIENCES CO.,LTD (CN) | 2025-09-04 | — | — | US | claimed |
| US-12398402-B2 | Reducing CD33 expression to selectively protect therapeutic cells | FRED HUTCHINSON CANCER CENTER (US) | 2025-08-26 | — | — | US | claimed |
| US-12390461-B2 | Modulators of RAR-related orphan receptors (RORs) | 11949098 CANADA INC. (CA) | 2025-08-19 | — | — | US | claimed |
| US-20250249125-A1 | ANTI-CD90 ANTIBODIES, BINDING FRAGMENTS, AND USES THEREOF | Fred Hutchison Cancer Center (US) | 2025-08-07 | — | — | US | claimed |
| WO-1998034621-A1 | COMPOSITION AND METHOD FOR SUPPLEMENTING TESTOSTERONE IN WOMEN WITH SYMPTOMS OF TESTOSTERONE DEFICIENCY | THERATECH, INC. (US) | 1998-08-13 | — | — | WO | claimed |
| US-5792456-A | Mutant BR96 antibodies reactive with human carcinomas | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-08-11 | — | — | US | claimed |
| WO-1998010069-A2 | E25a PROTEIN, METHODS FOR PRODUCTION AND USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-03-12 | — | — | WO | claimed |
| WO-1997041865-A1 | TOPICAL PENILE ANDROGEN APPLICATION FOR TREATMENT OF ERECTILE DYSFUNCTION | AZUPHARMA GMBH (DE) | 1997-11-13 | — | — | WO | claimed |
| US-5581002-A | BLOCKING WITH BUTYLDIMETHYLSILANYL CHLORIDE; ALKYLATION; OZONOLYZING WITH SODIUM HYPOCHLORITE; DEBLOCKING | ABBOTT LABORATORIES (US) | 1996-12-03 | — | — | US | claimed |
| EP-0699756-A1 | Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas | Bristol-Myers Squibb Company (US) | 1996-03-06 | — | — | EP | claimed |
| US-5391776-A | A bisphosphonate gonanes; selective absorbed by bone; therapy agent for osteoporosis | MITSUBISHI KASEI CORPORATION (JP) | 1995-02-21 | — | — | US | claimed |
| EP-0251905-B1 | Esters of alginic acid | FIDIA SPA (IT) | 1994-11-02 | — | — | EP | claimed |
| EP-0555845-A2 | Steroid derivatives | MITSUBISHI KASEI CORPORATION (JP) | 1993-08-18 | — | — | EP | claimed |
| EP-0496520-A1 | Novel bone acting agents | MERCK & CO. INC. (US) | 1992-07-29 | — | — | EP | claimed |